Table 1. Clinical data of the patients.

Patient characteristics	Group 1 (n = 7)	Group 2 (n = 16)	p value
Age, years	49±8	53±7	0.219
Male sex	2 (29)	3 (19)	0.621
Hypertension history, years	4.8±5.8	4.5±4.2.	0.900
Body weight, kg	61±11	60±10	0.768
Body height, cm	160±9	161±8	0.830
Creatinine	0.8±0.2	0.9±0.2	0.246
SBP, mmHg	150±22	145±18	0.523
DBP, mmHg	94±13	87±10	0.180
Potassium, mmol/L	3.6±0.7	4.1±0.3	0.122
PAC, ng/dL	77±42	26±19	0.019
PRA, ng/mL/h	0.6±0.8	7.0±8.3	0.008
ARR	2638±4310	15±18	0.158
Log PAC	1.8±0.3	1.4±0.2	0.001
Log PRA	−0.8±0.9	0.5±0.5	<0.001
Log ARR	2.6±1.1	0.8±0.6	0.004
Number of anti-hypertensive agent	2.1±1.3	1.6±1.0	0.252
Galectin-3, ng/ml	2.1±0.9	1.2±0.7	0.020

Values are mean ± SD or number (percentage). APA  =  aldosterone producing adenoma; EH =  essential hypertension; SBP  =  systolic blood pressure; DBP  =  diastolic blood pressure; PAC  =  plasma aldosterone concentration; PRA  =  plasma renin activity; ARR  =  aldosterone-renin ratio.